Understand Stock

$XLO

$8.10 -$0.15 (1.82%)

Deep Research with AI Research

Overview

$XLO Overview Financials SEC Filings Executives News

Specialized Tools

Valuations P Insider Transactions P Congressional Trades P

Insider Transactions

Insider Transaction Summary

SCIENCES, INC. GILEAD

40,384,266 shares

Net: +30,409,000 B/S: ∞

Life Sciences Associates, LP BCIP

2,802,225 shares

Net: 0 B/S: -

Venture Fund XI, L.P. Atlas

2,019,563 shares

Net: 0 B/S: -

Impact Medicine Fund LP SV7

1,613,632 shares

Net: 0 B/S: -

PHARMACEUTICAL CO LTD TAKEDA

1,475,121 shares

Net: 0 B/S: -

Venture Fund IV, L.P. RiverVest

1,441,444 shares

Net: 0 B/S: -

Springs Capital Management LP Rock

1,256,472 shares

Net: 0 B/S: -

MANAGEMENT COMPANY, L.P. (SERIES C) DEERFIELD

1,143,972 shares

Net: 0 B/S: -

CITY CAPITAL LLC BAY

1,129,490 shares

Net: 0 B/S: -

LLC FMR

815,788 shares

Net: 0 B/S: -

KGaA Merck

416,060 shares

Net: 0 B/S: -

Rene Russo

325,422 shares

Net: +3,416,094 B/S: ∞

Ltd FIL

218,705 shares

Net: 0 B/S: -

Venture Investments, LLC Alexandria

166,423 shares

Net: 0 B/S: -

Martin H. Jr. Huber

136,500 shares

Net: 0 B/S: -

Akintunde Olatokumbo Bello

62,000 shares

Net: +62,000 B/S: ∞

Salvatore Giovine

49,500 shares

Net: 0 B/S: -

Katarina Luptakova

33,250 shares

Net: +1,049,300 B/S: ∞

ROBERT W. ROSS

31,000 shares

Net: +31,000 B/S: ∞

Christina Rossi

31,000 shares

Net: +31,000 B/S: ∞

Yuan Xu

31,000 shares

Net: +31,000 B/S: ∞

Sara Bonstein

31,000 shares

Net: +31,000 B/S: ∞

Daniel J. Curran

31,000 shares

Net: +31,000 B/S: ∞

Aoife Brennan

31,000 shares

Net: +31,000 B/S: ∞

Paul J Clancy

31,000 shares

Net: +31,000 B/S: ∞

Christopher James Frankenfield

24,766 shares

Net: +1,451,044 B/S: 229.47

Edward C English

24,000 shares

Net: 0 B/S: -

Michael Jay Ross

13,200 shares

Net: 0 B/S: -

Tomas J. Heyman

13,200 shares

Net: 0 B/S: -

Cheryl R Blanchard

10,000 shares

Net: +10,000 B/S: ∞

James Samuel Shannon

10,000 shares

Net: +106,000 B/S: ∞

Kevin M. Brennan

6,371 shares

Net: +175,095 B/S: 127.01

Insider Name	Current Shares	Net Change (1yr)	Buy/Sell Ratio
SCIENCES, INC. GILEAD	40,384,266	+30,409,000	∞
Life Sciences Associates, LP BCIP	2,802,225	0	-
Venture Fund XI, L.P. Atlas	2,019,563	0	-
Impact Medicine Fund LP SV7	1,613,632	0	-
PHARMACEUTICAL CO LTD TAKEDA	1,475,121	0	-
Venture Fund IV, L.P. RiverVest	1,441,444	0	-
Springs Capital Management LP Rock	1,256,472	0	-
MANAGEMENT COMPANY, L.P. (SERIES C) DEERFIELD	1,143,972	0	-
CITY CAPITAL LLC BAY	1,129,490	0	-
LLC FMR	815,788	0	-
KGaA Merck	416,060	0	-
Rene Russo	325,422	+3,416,094	∞
Ltd FIL	218,705	0	-
Venture Investments, LLC Alexandria	166,423	0	-
Martin H. Jr. Huber	136,500	0	-
Akintunde Olatokumbo Bello	62,000	+62,000	∞
Salvatore Giovine	49,500	0	-
Katarina Luptakova	33,250	+1,049,300	∞
ROBERT W. ROSS	31,000	+31,000	∞
Christina Rossi	31,000	+31,000	∞
Yuan Xu	31,000	+31,000	∞
Sara Bonstein	31,000	+31,000	∞
Daniel J. Curran	31,000	+31,000	∞
Aoife Brennan	31,000	+31,000	∞
Paul J Clancy	31,000	+31,000	∞
Christopher James Frankenfield	24,766	+1,451,044	229.47
Edward C English	24,000	0	-
Michael Jay Ross	13,200	0	-
Tomas J. Heyman	13,200	0	-
Cheryl R Blanchard	10,000	+10,000	∞
James Samuel Shannon	10,000	+106,000	∞
Kevin M. Brennan	6,371	+175,095	127.01

Individual Transactions

April 15, 2026

Cheryl R Blanchard

Grant/Award Acquisition

Change: +10,000

Price: $0.00

Shares: 10,000

Value: +$0

Insider	Filing Date	Transaction	Shares	Change	Price	Value
Cheryl R Blanchard	Apr 16	Grant/Award Acquisition (A) Compensation/Award	10,000	+10,000	$0.00	+$0

March 26, 2026

James Samuel Shannon

Open Market Purchase

Change: +5,000

Price: $8.79

Shares: 10,000

Value: +$43,950

Insider	Filing Date	Transaction	Shares	Change	Price	Value
James Samuel Shannon	Mar 30	Open Market Purchase (P) Market Purchase	10,000	+5,000	$8.79	+$43,950

February 13, 2026

SCIENCES, INC. GILEAD

Open Market Purchase

Change: +3,739,000

Price: $0.53

Shares: 40,384,266

Value: +$1,999,991

Insider	Filing Date	Transaction	Shares	Change	Price	Value
SCIENCES, INC. GILEAD	Feb 17	Open Market Purchase (P) Market Purchase	40,384,266	+3,739,000	$0.53	+$1,999,991

January 02, 2026

Kevin M. Brennan

Open Market Sale

Change: -1,826

Price: $0.64

Shares: 6,371

Value: -$1,174

Christopher James Frankenfield

Open Market Sale

Change: -7,030

Price: $0.64

Shares: 24,766

Value: -$4,521

Insider	Filing Date	Transaction	Shares	Change	Price	Value
Kevin M. Brennan	Jan 05	Open Market Sale (S) Market Sale	6,371	-1,826	$0.64	-$1,174
Christopher James Frankenfield	Jan 05	Open Market Sale (S) Market Sale	24,766	-7,030	$0.64	-$4,521

January 01, 2026

Katarina Luptakova

Option Exercise/Conversion

Change: +16,625

Price: $0.00

Shares: 33,250

Value: +$0

Kevin M. Brennan

Option Exercise/Conversion

Change: +5,000

Price: $0.00

Shares: 8,197

Value: +$0

Christopher James Frankenfield

Option Exercise/Conversion

Change: +19,375

Price: $0.00

Shares: 31,796

Value: +$0

Rene Russo

Option Exercise/Conversion

Change: +44,250

Price: $0.00

Shares: 325,422

Value: +$0

Insider	Filing Date	Transaction	Shares	Change	Price	Value
Katarina Luptakova	Jan 05	Option Exercise/Conversion (M) Compensation/Award	33,250	+16,625	$0.00	+$0
Kevin M. Brennan	Jan 05	Option Exercise/Conversion (M) Compensation/Award	8,197	+5,000	$0.00	+$0
Christopher James Frankenfield	Jan 05	Option Exercise/Conversion (M) Compensation/Award	31,796	+19,375	$0.00	+$0
Rene Russo	Jan 05	Option Exercise/Conversion (M) Compensation/Award	325,422	+44,250	$0.00	+$0

December 31, 2025

Katarina Luptakova

Grant/Award Acquisition

Change: +451,885

Price: $0.00

Shares: 451,885

Value: +$0

Kevin M. Brennan

Grant/Award Acquisition

Change: +95,221

Price: $0.00

Shares: 95,221

Value: +$0

Christopher James Frankenfield

Grant/Award Acquisition

Change: +668,789

Price: $0.00

Shares: 668,789

Value: +$0

Rene Russo

Grant/Award Acquisition

Change: +1,500,258

Price: $0.00

Shares: 1,500,258

Value: +$0

Insider	Filing Date	Transaction	Shares	Change	Price	Value
Katarina Luptakova	Jan 05	Grant/Award Acquisition (A) Compensation/Award	451,885	+451,885	$0.00	+$0
Kevin M. Brennan	Jan 05	Grant/Award Acquisition (A) Compensation/Award	95,221	+95,221	$0.00	+$0
Christopher James Frankenfield	Jan 05	Grant/Award Acquisition (A) Compensation/Award	668,789	+668,789	$0.00	+$0
Rene Russo	Jan 05	Grant/Award Acquisition (A) Compensation/Award	1,500,258	+1,500,258	$0.00	+$0

November 26, 2025

SCIENCES, INC. GILEAD

In/At-money Exercise

Change: +13,335,000

Price: $0.75

Shares: 36,645,266

Value: +$9,999,916

Insider	Filing Date	Transaction	Shares	Change	Price	Value
SCIENCES, INC. GILEAD	Dec 01	In/At-money Exercise (X) Derivative Exercise	36,645,266	+13,335,000	$0.75	+$9,999,916

November 21, 2025

Kevin M. Brennan

Grant/Award Acquisition

Change: +131,700

Price: $0.00

Shares: 131,700

Value: +$0

Kevin M. Brennan

Disposition to Issuer

Change: -55,000

Price: $0.00

Shares: 0

Value: -$0

Rene Russo

Grant/Award Acquisition

Change: +2,075,000

Price: $0.00

Shares: 2,075,000

Value: +$0

Rene Russo

Disposition to Issuer

Change: -239,703

Price: $0.00

Shares: 0

Value: -$0

Christopher James Frankenfield

Disposition to Issuer

Change: -155,090

Price: $0.00

Shares: 0

Value: -$0

Christopher James Frankenfield

Grant/Award Acquisition

Change: +925,000

Price: $0.00

Shares: 925,000

Value: +$0

Insider	Filing Date	Transaction	Shares	Change	Price	Value
Kevin M. Brennan	Nov 25	Grant/Award Acquisition (A) Compensation/Award	131,700	+131,700	$0.00	+$0
Kevin M. Brennan	Nov 25	Disposition to Issuer (D) Payment to Issuer	0	-55,000	$0.00	-$0
Rene Russo	Nov 25	Grant/Award Acquisition (A) Compensation/Award	2,075,000	+2,075,000	$0.00	+$0
Rene Russo	Nov 25	Disposition to Issuer (D) Payment to Issuer	0	-239,703	$0.00	-$0
Christopher James Frankenfield	Nov 25	Disposition to Issuer (D) Payment to Issuer	0	-155,090	$0.00	-$0
Christopher James Frankenfield	Nov 25	Grant/Award Acquisition (A) Compensation/Award	925,000	+925,000	$0.00	+$0